Latest News

Frtek Co.Ltd. ( KOSDAQ:073540 ) shareholders have had their patience rewarded with a 26% share price jump in the last...

Key Insights Significant control over Botanix Pharmaceuticals by individual investors implies that the general public...

Bhagwan Marine ( ASX:BWN ) Full Year 2025 Results Key Financial Results Revenue: AU$283.0m (up 5.3% from FY 2024). Net...

Key Insights Given the large stake in the stock by institutions, Coast Entertainment Holdings' stock price might be...

Steadfast Group ( ASX:SDF ) Full Year 2025 Results Key Financial Results Revenue: AU$2.06b (up 17% from FY 2024). Net...

Nanoveu ( ASX:NVU ) First Half 2025 Results Key Financial Results Net loss: AU$2.97m (loss widened by 171% from 1H...

Codeifai ( ASX:CDE ) First Half 2025 Results Key Financial Results Revenue: AU$354.0k (down 33% from 1H 2024). Net...

The Fenix Resources Limited ( ASX:FEX ) share price has done very well over the last month, posting an excellent gain...

Lifestyle Communities Limited ( ASX:LIC ) shareholders are no doubt pleased to see that the share price has bounced 26...

Despite an already strong run, NTAW Holdings Limited ( ASX:NTD ) shares have been powering on, with a gain of 38% in...

Key Insights Findi's significant retail investors ownership suggests that the key decisions are influenced by...

As the Australian market navigates a period of uncertainty, with key indices like the ASX struggling to maintain momentum amid mixed signals from global markets, investors are keenly watching for opportunities that offer stability and income. In such conditions, dividend stocks can be an attractive option, providing regular income streams and potential resilience against market volatility.

As September unfolds, the Australian market faces a cautious atmosphere with the ASX struggling to climb back above 9,000 points amid mixed performances across sectors. In such an environment, identifying growth companies with high insider ownership can be particularly appealing, as these stocks often indicate strong confidence from those who know the business best and may offer resilience in uncertain times.

Key Insights Institutions' substantial holdings in Pan American Silver implies that they have significant influence...

NetApp ( NASDAQ:NTAP ) First Quarter 2026 Results Key Financial Results Revenue: US$1.56b (up 1.2% from 1Q 2025). Net...

Despite announcing strong earnings, LSL Pharma Group Inc.'s ( CVE:LSL ) stock was sluggish. Our analysis uncovered some...

Dell Technologies ( NYSE:DELL ) Second Quarter 2026 Results Key Financial Results Revenue: US$29.8b (up 19% from 2Q...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The board of Air New Zealand Limited ( NZSE:AIR ) has announced that it will pay a dividend on the 25th of September...

Delegat Group ( NZSE:DGL ) Full Year 2025 Results Key Financial Results Revenue: NZ$349.6m (down 7.6% from FY 2024...

As the Canadian market navigates through a period of economic contraction, with GDP declining by 1.6% in Q2, investors are closely watching for potential opportunities that may arise from anticipated monetary easing by the Bank of Canada. In this context, penny stocks—often smaller or newer companies—remain an intriguing investment area for those looking to uncover hidden value and growth potential. While traditionally considered speculative, penny stocks backed by strong financials can offer...

Restaurant Brands New Zealand Limited's ( NZSE:RBD ) solid earnings announcement recently didn't do much to the stock...

Telix Pharmaceuticals (ASX:TLX) saw its share price drop 24% last week following regulatory setbacks. The decline was driven by the FDA's issuance of a Complete Response Letter, highlighting deficiencies in Telix's Biologics License Application for TLX250-CDx. This regulatory challenge necessitates manufacturing and data improvements before resubmission. While the broader market experienced a tech-led downturn, Telix's drop contrasts with this trend, largely reflecting concerns specific to...

IQVIA Holdings (IQV) recently appointed Michael Fedock as the future CFO, replacing the retiring Ron Bruehlman, marking a significant leadership transition. The company's shares rose 29% last quarter, a period rich with impactful announcements such as a strategic collaboration with Flagship Pioneering and a partnership with Kexing Biopharm. Amid a fluctuating market, downturns in tech stocks, and significant index drops, IQVIA's resilient performance suggests the strength of its initiatives...